InnovAge Holding Corp. (INNV) stock

INNVNasdaqServices-Health ServicesFiscal year ends June 30

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3064% above fair value

$9.47+0.07 (+0.74%)

Close on Nov 13, 2026Market cap $1.29BP/E –Yield –

InnovAge EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

InnovAge's EV/EBITDA was 50.6× on Nov 11, 2026, against 257.2× a year earlier. Over the last 3 years it ranged from 10.8× to 272.2×, with a median of 58.0×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	50.6×	−201.9
2025	Dec 31, 2025	252.5×	+62.5
2024	Dec 31, 2024	190.0×	+113.0
2022	Oct 31, 2022	77.0×	+66.2
2021	Dec 31, 2021	10.8×	–

Where these numbers come from

Parsed from the XBRL in InnovAge's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is INNV.

Compare: INNV vs PNTG · INNV vs PIII · INNV vs USPH · INNV vs PRVA · INNV vs LFST

Revenue growth15.9% · median 19.2%

Gross margin23.0% · median 18.5%

Operating margin0.3% · median 5.8%

Net margin-0.3% · median 3.1%

Company	Revenue	Growth
PRVA	$2.43B	+19.2%
LFST	$1.68B	+22.6%
PIII	$1.55B	+7.5%
PNTG	$1.17B	+38.7%
INNV	$989.71M	+15.9%
USPH	$837.63M	+10.4%

Company

Next earnings (est.): Feb 2, 2027, during market hours
Exchange: Nasdaq
Industry: Services-Health Services
Fiscal year ends: June 30
Employees: 2,500
Held by institutions: 13.5%
Auditor: DELOITTE & TOUCHE LLP
SEC CIK: 1834376

Advertisement
300 × 250

See a number that looks wrong?

InnovAge EV/EBITDA

EV/EBITDA at the end of each year

More InnovAge figures